HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Camilleri Selected Research

TD-5108

2/2014Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
1/2010Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Camilleri Research Topics

Disease

36Constipation
06/2018 - 01/2000
25Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2017 - 01/2000
15Pain (Aches)
01/2018 - 01/2000
13Dyspepsia (Indigestion)
01/2018 - 10/2000
10Gastroparesis
01/2018 - 09/2009
10Abdominal Pain (Pain, Abdominal)
05/2017 - 01/2000
6Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2015 - 07/2002
6Diarrhea
04/2012 - 02/2001
5Hypersensitivity (Allergy)
06/2013 - 08/2006
4Nausea
01/2018 - 02/2002
4Vomiting
01/2018 - 01/2000
4Neoplasms (Cancer)
05/2017 - 02/2001
4Diabetes Mellitus
03/2009 - 06/2001
4Visceral Pain
03/2009 - 08/2004
4Ileus
04/2005 - 07/2001
3Obesity
07/2011 - 05/2007
2Cardiac Arrhythmias (Arrythmia)
01/2018 - 11/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2015 - 09/2012
2Hyperplasia
02/2014 - 10/2004
2Headache (Headaches)
02/2014 - 11/2010
2Short Bowel Syndrome
09/2012 - 05/2001
2Gastroesophageal Reflux (GERD)
09/2012 - 08/2003
2Ulcerative Colitis
09/2012 - 05/2001
2Medically Unexplained Symptoms
09/2009 - 06/2004
2Heartburn (Pyrosis)
03/2009 - 10/2000
2Body Weight (Weight, Body)
06/2008 - 05/2001
2Colitis
02/2007 - 05/2001
2Inflammation (Inflammations)
01/2007 - 05/2001
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2001 - 03/2001
1Weight Loss (Weight Reduction)
01/2018
1Long QT Syndrome
01/2018
1Ventricular Fibrillation
01/2018
1Torsades de Pointes (Torsade de Pointes)
01/2018
1Opioid-Induced Constipation
01/2018
1Atrial Fibrillation
11/2017
1Colic (Abdominal Cramps)
02/2017
1Bradycardia
01/2016
1Hypotension (Low Blood Pressure)
01/2016
1Muscle Rigidity
01/2016
1Colonic Pseudo-Obstruction (Ogilvie Syndrome)
12/2015
1Chronic Pain
10/2014

Drug/Important Bio-Agent (IBA)

10Opioid Analgesics (Opioids)IBA
01/2018 - 02/2001
9alosetron (Lotronex)FDA Link
02/2007 - 01/2000
8Pharmaceutical PreparationsIBA
01/2018 - 01/2000
7Biomarkers (Surrogate Marker)IBA
10/2015 - 04/2004
6prucaloprideIBA
09/2016 - 02/2001
5Bile Acids and Salts (Bile Acids)IBA
02/2017 - 07/2009
4Serotonin (5 Hydroxytryptamine)IBA
02/2014 - 03/2000
3Capsules (Microcapsules)IBA
06/2018 - 08/2010
3CannabinoidsIBA
01/2018 - 08/2008
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018 - 03/2001
3Antidepressive Agents (Antidepressants)IBA
01/2018 - 02/2001
3Proteins (Proteins, Gene)FDA Link
11/2016 - 06/2004
3Opiate AlkaloidsIBA
05/2012 - 04/2005
3Clonidine (ST 155)FDA LinkGeneric
04/2009 - 06/2000
3Nerve Growth Factors (Neurotrophins)IBA
04/2008 - 07/2000
3Serotonin 5-HT3 Receptor AntagonistsIBA
02/2007 - 09/2001
3Glucose (Dextrose)FDA LinkGeneric
04/2006 - 03/2001
3tegaserod (Zelnorm)FDA Link
03/2001 - 03/2000
2Exenatide (Byetta)FDA Link
01/2018 - 07/2012
2mu Opioid Receptors (mu Opioid Receptor)IBA
01/2018 - 08/2004
2salicylhydroxamic acid (SHAM)IBA
07/2017 - 06/2008
2relamorelinIBA
11/2016 - 03/2015
25-HT4 Serotonin ReceptorsIBA
09/2016 - 03/2015
2ElectrolytesIBA
09/2016 - 05/2001
2LaxativesIBA
09/2016 - 10/2000
2Neostigmine (Neostigmine Bromide)IBA
01/2016 - 12/2015
2Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2015 - 03/2007
2Proton Pump InhibitorsIBA
11/2015 - 10/2006
2TD-5108IBA
02/2014 - 01/2010
2Serotonin 5-HT4 Receptor AgonistsIBA
02/2014 - 10/2007
2Neurotransmitter Agents (Neurotransmitter)IBA
06/2013 - 10/2004
2pramlintide (Symlin)FDA Link
07/2012 - 04/2002
2goblet cell silencer inhibitorIBA
05/2012 - 09/2009
2N 30IBA
03/2010 - 05/2001
2kappa Opioid Receptors (kappa Opioid Receptor)IBA
03/2009 - 08/2004
2asimadolineIBA
09/2008 - 06/2008
2AntioxidantsIBA
04/2008 - 03/2008
2Narcotic Antagonists (Opioid Antagonists)IBA
10/2007 - 04/2005
2Parasympatholytics (Antispasmodics)IBA
08/2002 - 02/2001
1Streptozocin (Streptozotocin)FDA Link
01/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1LiraglutideFDA Link
01/2018
1Glucagon-Like Peptide-1 ReceptorIBA
01/2018
1AntralIBA
01/2018
1antiarrhythmic peptide (AAP)IBA
05/2017
1Heme Oxygenase-1IBA
11/2016
1Hemin (Panhematin)FDA Link
11/2016
1AlbuminsIBA
11/2016
1Ghrelin ReceptorsIBA
11/2016
1polyethylene glycol 3350 (miralax)FDA LinkGeneric
09/2016
1AtropineFDA LinkGeneric
01/2016
1Colesevelam Hydrochloride (Welchol)FDA Link
03/2015
1Opioid Receptors (Opioid Receptor)IBA
10/2014
1ATI 7505IBA
02/2014
1LigandsIBA
11/2013
1GhrelinIBA
11/2013

Therapy/Procedure

15Therapeutics
11/2017 - 10/2000
4Drug Therapy (Chemotherapy)
12/2009 - 07/2006
1Investigational Therapies (Experimental Therapy)
01/2018